Howe & Rusling Inc Novartis Ag Transaction History

Howe & Rusling Inc

$1.16 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $61,404 - $71,814	-823 Reduced 32.22%	1,731 $132,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $128,832 - $150,000	1,600 Added 167.71%	2,554 $216,000
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $5,607 - $6,343	70 Added 7.92%	954 $84,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $5,818 - $6,433	73 Added 9.0%	884 $77,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $1,875 - $2,071	-22 Reduced 2.64%	811 $74,000
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $9,602 - $11,324	-115 Reduced 12.13%	833 $71,000
Q4 2020 Feb 08, 2021	SELL	$78.07 - $94.43 $12,022 - $14,542	-154 Reduced 13.97%	948 $90,000
Q3 2020 Nov 06, 2020	BUY	$82.14 - $91.0 $4,928 - $5,460	60 Added 5.76%	1,102 $96,000
Q2 2020 Jul 15, 2020	BUY	$80.93 - $91.1 $22,579 - $25,416	279 Added 36.57%	1,042 $91,000
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $15,194 - $21,287	-215 Reduced 21.98%	763 $63,000
Q3 2019 Oct 31, 2019	SELL	$85.54 - $94.26 $2,138 - $2,356	-25 Reduced 2.49%	978 $85,000
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $44,561 - $54,844	-591 Reduced 37.08%	1,003 $92,000
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $9,415 - $10,768	-125 Reduced 7.27%	1,594 $153,000
Q4 2018 Feb 04, 2019	BUY	$73.66 - $82.02 $1,031 - $1,148	14 Added 0.82%	1,719 $148,000
Q3 2018 Nov 07, 2018	BUY	$66.94 - $77.43 $38,490 - $44,522	575 Added 50.88%	1,705 $147,000
Q2 2018 Jul 31, 2018	SELL	$64.91 - $73.36 $14,604 - $16,506	-225 Reduced 16.61%	1,130 $85,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $12,529 - $14,978	-178 Reduced 11.61%	1,355 $110,000
Q4 2017 Jan 24, 2018	BUY	$72.33 - $77.64 $4,195 - $4,503	58 Added 3.93%	1,533 $129,000
Q3 2017 Oct 18, 2017	BUY	$74.14 - $77.27 $109,356 - $113,973	1,475	1,475 $127,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account